The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Gastrointestinal OTC Drugs-Global Market Insights and Sales Trends 2024

Gastrointestinal OTC Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :

Report Code : 1844639

No of Pages : 104

Ask Your Query

Report Description
Table of Content

Synopsis
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
The global Gastrointestinal OTC Drugs market size is expected to reach US$ 8483.1 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Gastrointestinal OTC Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Gastrointestinal OTC Drugs market. Laxatives, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Flatulents segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Gastrointestinal OTC Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Gastrointestinal OTC Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal OTC Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gastrointestinal OTC Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gastrointestinal OTC Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal OTC Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gastrointestinal OTC Drugs covered in this report include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc.
The global Gastrointestinal OTC Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Global Gastrointestinal OTC Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal OTC Drugs market, Segment by Type:
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Global Gastrointestinal OTC Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gastrointestinal OTC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Gastrointestinal OTC Drugs Market Overview
1.1 Gastrointestinal OTC Drugs Product Overview
1.2 Gastrointestinal OTC Drugs Market Segment by Type
1.2.1 Laxatives
1.2.2 Anti-Flatulents
1.2.3 H2-Antaginists
1.2.4 Anti-Diarrheals
1.2.5 PPIs
1.2.6 Anti-Emetics
1.2.7 Other
1.3 Global Gastrointestinal OTC Drugs Market Size by Type
1.3.1 Global Gastrointestinal OTC Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Type (2018-2023)
2 Global Gastrointestinal OTC Drugs Market Competition by Company
2.1 Global Top Players by Gastrointestinal OTC Drugs Sales (2018-2023)
2.2 Global Top Players by Gastrointestinal OTC Drugs Revenue (2018-2023)
2.3 Global Top Players by Gastrointestinal OTC Drugs Price (2018-2023)
2.4 Global Top Manufacturers Gastrointestinal OTC Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal OTC Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gastrointestinal OTC Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Gastrointestinal OTC Drugs Market
2.8 Key Manufacturers Gastrointestinal OTC Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gastrointestinal OTC Drugs Status and Outlook by Region
3.1 Global Gastrointestinal OTC Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gastrointestinal OTC Drugs Historic Market Size by Region
3.2.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Region
3.3.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Gastrointestinal OTC Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Gastrointestinal OTC Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gastrointestinal OTC Drugs by Application
4.1 Gastrointestinal OTC Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Gastrointestinal OTC Drugs Market Size by Application
4.2.1 Global Gastrointestinal OTC Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Gastrointestinal OTC Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gastrointestinal OTC Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gastrointestinal OTC Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gastrointestinal OTC Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gastrointestinal OTC Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gastrointestinal OTC Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gastrointestinal OTC Drugs Sales Breakdown by Application (2018-2023)
5 North America Gastrointestinal OTC Drugs by Country
5.1 North America Gastrointestinal OTC Drugs Historic Market Size by Country
5.1.1 North America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Gastrointestinal OTC Drugs Sales in Value by Country (2018-2023)
5.2 North America Gastrointestinal OTC Drugs Forecasted Market Size by Country
5.2.1 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Gastrointestinal OTC Drugs Sales in Value by Country (2024-2029)
6 Europe Gastrointestinal OTC Drugs by Country
6.1 Europe Gastrointestinal OTC Drugs Historic Market Size by Country
6.1.1 Europe Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Gastrointestinal OTC Drugs Sales in Value by Country (2018-2023)
6.2 Europe Gastrointestinal OTC Drugs Forecasted Market Size by Country
6.2.1 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Gastrointestinal OTC Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Gastrointestinal OTC Drugs by Region
7.1 Asia-Pacific Gastrointestinal OTC Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gastrointestinal OTC Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gastrointestinal OTC Drugs Sales in Value by Region (2024-2029)
8 Latin America Gastrointestinal OTC Drugs by Country
8.1 Latin America Gastrointestinal OTC Drugs Historic Market Size by Country
8.1.1 Latin America Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gastrointestinal OTC Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Gastrointestinal OTC Drugs Forecasted Market Size by Country
8.2.1 Latin America Gastrointestinal OTC Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gastrointestinal OTC Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Gastrointestinal OTC Drugs by Country
9.1 Middle East and Africa Gastrointestinal OTC Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gastrointestinal OTC Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gastrointestinal OTC Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
10.4.5 Bayer Recent Development
10.5 Procter & Gamble
10.5.1 Procter & Gamble Company Information
10.5.2 Procter & Gamble Introduction and Business Overview
10.5.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
10.5.5 Procter & Gamble Recent Development
10.6 Perrigo
10.6.1 Perrigo Company Information
10.6.2 Perrigo Introduction and Business Overview
10.6.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
10.6.5 Perrigo Recent Development
10.7 Abbott
10.7.1 Abbott Company Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
10.7.5 Abbott Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
10.8.5 Sanofi Recent Development
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Company Information
10.9.2 Teva Pharmaceutical Introduction and Business Overview
10.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
10.9.5 Teva Pharmaceutical Recent Development
10.10 Nestle
10.10.1 Nestle Company Information
10.10.2 Nestle Introduction and Business Overview
10.10.3 Nestle Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Nestle Gastrointestinal OTC Drugs Products Offered
10.10.5 Nestle Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Information
10.11.2 Boehringer Ingelheim Introduction and Business Overview
10.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Reckitt Benckiser
10.12.1 Reckitt Benckiser Company Information
10.12.2 Reckitt Benckiser Introduction and Business Overview
10.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Products Offered
10.12.5 Reckitt Benckiser Recent Development
10.13 Purdue Pharma
10.13.1 Purdue Pharma Company Information
10.13.2 Purdue Pharma Introduction and Business Overview
10.13.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Purdue Pharma Gastrointestinal OTC Drugs Products Offered
10.13.5 Purdue Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gastrointestinal OTC Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gastrointestinal OTC Drugs Industrial Chain Analysis
11.4 Gastrointestinal OTC Drugs Market Dynamics
11.4.1 Gastrointestinal OTC Drugs Industry Trends
11.4.2 Gastrointestinal OTC Drugs Market Drivers
11.4.3 Gastrointestinal OTC Drugs Market Challenges
11.4.4 Gastrointestinal OTC Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gastrointestinal OTC Drugs Distributors
12.3 Gastrointestinal OTC Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Medical Coatings Market - Industry Trends and Forecast to 2031

Global Pediatric MRI Systems Market Research Report 2024

Global Oridonin Market Research Report 2024

Global Dual Fetal Monitors Market Research Report 2024

Global Animal Examination Otoscopes Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}